Peter H Wiernik Selected Research

Neutropenia

1/2008	Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia.
1/2005	Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter H Wiernik Research Topics

Disease

18	Neoplasms (Cancer) 01/2018 - 03/2004
12	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 09/2003
12	Leukemia 01/2022 - 01/2004
10	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 01/2003
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2016 - 01/2003
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2013 - 01/2003
8	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 10/2008
8	Lymphoma (Lymphomas) 01/2016 - 01/2003
7	Acute Promyelocytic Leukemia 01/2023 - 12/2002
6	Multiple Myeloma 08/2017 - 10/2008
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 03/2005
5	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 07/2012 - 07/2009
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2014 - 11/2009
4	Hodgkin Disease (Hodgkin's Disease) 03/2013 - 04/2006
4	Disease Progression 11/2009 - 02/2004
3	Renal Cell Carcinoma (Grawitz Tumor) 02/2021 - 12/2006
3	Philadelphia Chromosome 02/2017 - 05/2009
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2014 - 11/2009
3	B-Cell Lymphoma (Lymphoma, B Cell) 03/2013 - 02/2010
3	Prostatic Neoplasms (Prostate Cancer) 03/2011 - 06/2004
3	Thrombotic Thrombocytopenic Purpura 03/2005 - 01/2002
2	Melanoma (Melanoma, Malignant) 02/2021 - 03/2005
2	Kidney Neoplasms (Kidney Cancer) 01/2018 - 12/2005
2	Hemorrhage 03/2017 - 11/2004
2	Anemia 04/2016 - 07/2003
2	Hemolysis 04/2016 - 01/2002
2	Hypersensitivity (Allergy) 02/2016 - 11/2004
2	Blast Crisis (Blast Phase) 09/2010 - 05/2006
2	Neutropenia 01/2008 - 01/2005
2	Dermatitis 03/2007 - 11/2004
2	Adenocarcinoma 03/2007 - 01/2002
2	Carcinoma (Carcinomatosis) 03/2006 - 12/2005
2	Neoplasm Metastasis (Metastasis) 08/2005 - 06/2004
2	Splenomegaly 04/2004 - 07/2003
1	Nervous System Diseases (Neurological Disorders) 01/2024
1	Hairy Cell Leukemia 01/2018
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2017
1	Pure Red-Cell Aplasia 04/2016
1	Polycythemia (Erythrocytosis) 02/2016

Drug/Important Bio-Agent (IBA)

7	Rituximab (Mabthera)FDA Link 01/2017 - 11/2004
6	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2017 - 12/2002
5	Interleukin-2 (IL2)IBA 02/2021 - 03/2005
5	AntigensIBA 01/2018 - 08/2005
5	Lenalidomide (CC 5013)FDA Link 03/2013 - 12/2006
4	Transcription Factors (Transcription Factor)IBA 02/2012 - 07/2009
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2011 - 08/2003
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 06/2004
3	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2011 - 09/2003
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2010 - 01/2004
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2004 - 01/2004
2	Arsenic Trioxide (Trisenox)FDA Link 01/2023 - 03/2004
2	AndrogensIBA 01/2018 - 06/2004
2	Monoclonal AntibodiesIBA 01/2017 - 11/2009
2	Thalidomide (Thalomid)FDA Link 03/2013 - 04/2009
2	Antineoplastic Agents (Antineoplastics)IBA 03/2013 - 04/2009
2	Dexamethasone (Maxidex)FDA LinkGeneric 07/2012 - 03/2007
2	AnthracyclinesIBA 12/2011 - 03/2004
2	fludarabineIBA 10/2011 - 01/2003
2	Tumor Biomarkers (Tumor Markers)IBA 03/2011 - 12/2005
2	Carboplatin (JM8)FDA LinkGeneric 09/2010 - 03/2007
2	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2010 - 04/2006
2	Prednisone (Sone)FDA LinkGeneric 10/2009 - 09/2003
2	Vincristine (Oncovin)FDA LinkGeneric 10/2009 - 09/2003
2	Immunoglobulins (Immunoglobulin)IBA 01/2008 - 03/2005
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2007 - 01/2003
2	Carbonic Anhydrases (Carbonic Anhydrase)IBA 12/2006 - 12/2005
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2006 - 06/2004
2	thiamine triphosphorate (TTP)IBA 03/2005 - 01/2005
2	Etoposide (VP 16)FDA LinkGeneric 01/2005 - 08/2003
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 09/2004 - 08/2003
2	SteroidsIBA 04/2004 - 01/2002
1	Naphazoline (All Clear)FDA LinkGeneric 01/2024
1	ChromatinIBA 01/2022
1	CholesterolIBA 01/2022
1	Mevalonic Acid (Mevalonate)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 02/2017
1	CD20 AntigensIBA 01/2017
1	fms-Like Tyrosine Kinase 3IBA 10/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2016
1	alvocidib (flavopiridol)IBA 06/2016
1	flavoneIBA 06/2016
1	IronIBA 04/2016
1	Antiviral Agents (Antivirals)IBA 04/2016
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 02/2016
1	Tyrosine (L-Tyrosine)FDA Link 02/2016
1	Erythropoietin FDA Link 02/2016
1	telomerase RNA (bTR)IBA 01/2016

Therapy/Procedure

29	Therapeutics 01/2023 - 12/2002
14	Drug Therapy (Chemotherapy) 01/2017 - 02/2004
8	Cell Transplantation 01/2020 - 08/2011
7	Hematopoietic Stem Cell Transplantation 01/2018 - 02/2004
6	Transplantation 01/2018 - 03/2010
5	Homologous Transplantation 07/2013 - 02/2008
4	Autologous Transplantation 04/2015 - 02/2004
4	Aftercare (After-Treatment) 01/2008 - 01/2003
3	Stem Cell Transplantation 08/2011 - 08/2008
2	Immunotherapy 01/2016 - 02/2010
2	Radiotherapy 10/2009 - 03/2007
2	Induction Chemotherapy 05/2006 - 01/2004
2	Intravenous Infusions 01/2005 - 08/2003